172 related articles for article (PubMed ID: 33424274)
1. Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability.
Faris TM; Harisa GI; Alanazi FK; Samy AM; Nasr FA
Saudi Pharm J; 2020 Dec; 28(12):1851-1867. PubMed ID: 33424274
[TBL] [Abstract][Full Text] [Related]
2. Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: Improved permeation, retention, and penetration.
Abdullah TA; Ibrahim NJ; Warsi MH
Int J Pharm Investig; 2016; 6(2):96-105. PubMed ID: 27051629
[TBL] [Abstract][Full Text] [Related]
3. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
4. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR
Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085
[TBL] [Abstract][Full Text] [Related]
5. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.
Yeh MK; Cheng KM; Hu CS; Huang YC; Young JJ
Acta Biomater; 2011 Oct; 7(10):3804-12. PubMed ID: 21742066
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three water-soluble polyphosphate tripolyphosphate, phytic acid, and sodium hexametaphosphate as crosslinking agents in chitosan nanoparticle formulation.
Sang Z; Qian J; Han J; Deng X; Shen J; Li G; Xie Y
Carbohydr Polym; 2020 Feb; 230():115577. PubMed ID: 31887915
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
Sharma M; Sharma R; Jain DK; Saraf A
Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
[TBL] [Abstract][Full Text] [Related]
8. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
10. The role of the lecithin addition in the properties and cytotoxic activity of chitosan and chondroitin sulfate nanoparticles containing curcumin.
Jardim KV; Siqueira JLN; Báo SN; Sousa MH; Parize AL
Carbohydr Polym; 2020 Jan; 227():115351. PubMed ID: 31590861
[TBL] [Abstract][Full Text] [Related]
11. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
12. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
[No Abstract] [Full Text] [Related]
13. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
[TBL] [Abstract][Full Text] [Related]
14. Potential Oral Anticancer Therapeutic Agents of Hexahydrocurcumin-Encapsulated Chitosan Nanoparticles against MDA-MB-231 Breast Cancer Cells.
Sorasitthiyanukarn FN; Muangnoi C; Gomez CB; Suksamrarn A; Rojsitthisak P; Rojsitthisak P
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839794
[TBL] [Abstract][Full Text] [Related]
15. Design-of-Experiment-Assisted Fabrication of Biodegradable Polymeric Nanoparticles: In Vitro Characterization, Biological Activity, and In Vivo Assessment.
Mir MA; Akhter MH; Afzal O; Rab SO; Altamimi ASA; Alossaimi MA; Nasar Mir Najib Ullah S; Jaremko M; Emwas AH; Ahmad S; Alam N; Ali MS
ACS Omega; 2023 Oct; 8(42):38806-38821. PubMed ID: 37901564
[TBL] [Abstract][Full Text] [Related]
16. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats.
Zhang Z; Bu H; Gao Z; Huang Y; Gao F; Li Y
Int J Pharm; 2010 Jul; 394(1-2):147-53. PubMed ID: 20435111
[TBL] [Abstract][Full Text] [Related]
17. Nutraceutical formulation, characterisation, and in-vitro evaluation of methylselenocysteine and selenocystine using food derived chitosan:zein nanoparticles.
Vozza G; Khalid M; Byrne HJ; Ryan SM; Frias JM
Food Res Int; 2019 Jun; 120():295-304. PubMed ID: 31000242
[TBL] [Abstract][Full Text] [Related]
18. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel-Loaded Chitosan-Cholesterol Conjugate-Based Self-Assembled Nanoparticles for Overcoming Multidrug Resistance in Cancer Cells.
Mu CF; Cui F; Yin YM; Cho HJ; Kim DD
Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32825000
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin and paclitaxel co-bound lactosylated albumin nanoparticles having targetability to hepatocellular carcinoma.
Thao LQ; Lee C; Kim B; Lee S; Kim TH; Kim JO; Lee ES; Oh KT; Choi HG; Yoo SD; Youn YS
Colloids Surf B Biointerfaces; 2017 Apr; 152():183-191. PubMed ID: 28110040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
